OBJECTIVE: Ankylosing spondylitis (AS), a chronic inflammatory disorder, has a notable association with HLA-B27. One hypothesis suggests that a common antigen that binds to HLA-B27 is important for AS disease pathogenesis. This study was undertaken to determine sequences and motifs that are shared among HLA-B27-positive AS patients, using T cell repertoire next-generation sequencing. METHODS: To identify motifs enriched among B27-positive AS patients, we performed T cell receptor β (TCRβ) repertoire sequencing on samples from 191 B27-positive AS patients, 43 B27-negative AS patients, and 227 controls, and we obtained >77 million TCRβ clonotype sequences. First, we assessed whether any of 50 previously published sequences were enriched in B27-positive AS patients. We then used training and test cohorts to identify discovered motifs that were enriched in B27-positive AS patients versus controls. RESULTS: Six previously published and 11 discovered motifs were enriched in the B27-positive AS samples as compared to controls. After combining motifs related by sequence, we identified a total of 15 independent motifs. Both the full set of 15 motifs and a set of 6 published motifs were enriched in the B27-positive AS patients as compared to B27-positive healthy individuals (P = 0.049 and P = 0.001, respectively). Using an independent cohort, we validated that at least some of these motifs were associated with AS, and not simply with B27-positive status. CONCLUSION: We identified TCRβ motifs that are enriched in B27-positive AS patients as compared to B27-positive healthy controls. This suggests that a common antigen, presented by HLA-B27 and detected by CD8+ T cells, may be associated with AS disease pathogenesis.
OBJECTIVE:Ankylosing spondylitis (AS), a chronic inflammatory disorder, has a notable association with HLA-B27. One hypothesis suggests that a common antigen that binds to HLA-B27 is important for AS disease pathogenesis. This study was undertaken to determine sequences and motifs that are shared among HLA-B27-positive AS patients, using T cell repertoire next-generation sequencing. METHODS: To identify motifs enriched among B27-positive AS patients, we performed T cell receptor β (TCRβ) repertoire sequencing on samples from 191 B27-positive AS patients, 43 B27-negative AS patients, and 227 controls, and we obtained >77 million TCRβ clonotype sequences. First, we assessed whether any of 50 previously published sequences were enriched in B27-positive AS patients. We then used training and test cohorts to identify discovered motifs that were enriched in B27-positive AS patients versus controls. RESULTS: Six previously published and 11 discovered motifs were enriched in the B27-positive AS samples as compared to controls. After combining motifs related by sequence, we identified a total of 15 independent motifs. Both the full set of 15 motifs and a set of 6 published motifs were enriched in the B27-positive AS patients as compared to B27-positive healthy individuals (P = 0.049 and P = 0.001, respectively). Using an independent cohort, we validated that at least some of these motifs were associated with AS, and not simply with B27-positive status. CONCLUSION: We identified TCRβ motifs that are enriched in B27-positive AS patients as compared to B27-positive healthy controls. This suggests that a common antigen, presented by HLA-B27 and detected by CD8+ T cells, may be associated with AS disease pathogenesis.
Authors: Ludmila Danilova; Valsamo Anagnostou; Franck Housseau; Kellie N Smith; Justina X Caushi; John-William Sidhom; Haidan Guo; Hok Yee Chan; Prerna Suri; Ada Tam; Jiajia Zhang; Margueritta El Asmar; Kristen A Marrone; Jarushka Naidoo; Julie R Brahmer; Patrick M Forde; Alexander S Baras; Leslie Cope; Victor E Velculescu; Drew M Pardoll Journal: Cancer Immunol Res Date: 2018-06-12 Impact factor: 11.151
Authors: Yuri B Lebedev; Thierry Mora; Aleksandra M Walczak; Mikhail V Pogorelyy; Anastasia A Minervina; Dmitriy M Chudakov; Ilgar Z Mamedov Journal: Elife Date: 2018-03-13 Impact factor: 8.140
Authors: Mikhail V Pogorelyy; Anastasia A Minervina; Mikhail Shugay; Dmitriy M Chudakov; Yuri B Lebedev; Thierry Mora; Aleksandra M Walczak Journal: PLoS Biol Date: 2019-06-13 Impact factor: 8.029
Authors: Mikhail V Pogorelyy; Alla D Fedorova; James E McLaren; Kristin Ladell; Dmitri V Bagaev; Alexey V Eliseev; Artem I Mikelov; Anna E Koneva; Ivan V Zvyagin; David A Price; Dmitry M Chudakov; Mikhail Shugay Journal: Genome Med Date: 2018-08-25 Impact factor: 11.117